ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
88,176.74
0.81%
S&P 500
5,776.65
0.16%
Dow Jones
42,587.50
0.01%
US Dollar vs Yen
150.4665
0.34%
Brent Oil
72.625
0.02%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Hepion Pharmaceuticals Inc (HEPA) 銘柄情報

Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals Inc (HEPA)

NASDAQ
0.713
0.00
(0.00%)
終了 3月26日 5:00AM
15分遅延
0.00
0.00
(0.00%)
取引時間後: -
15分遅延

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
0.713
買値
0.6818
売値
0.71
出来高
-
0.00 日の範囲 0.00
0.0203 52 週間の範囲 2.8999
時価総額
4.961M
前日終値
0.713
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
21,460,241
発行済株式数
6,958,371
配当利回り
-
PER
-0.10
1 株当たり利益 (EPS)
-7.03
歳入
-
純利益
-48.93M

Hepion Pharmaceuticals Inc について

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
www.hepion.com
本社
Wilmington, Delaware, USA
設立
-
Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker HEPA. The last closing price for Hepion Pharmaceuticals was US$0.71. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of US$ 0.0203 to US$ 2.8999.

Hepion Pharmaceuticals currently has 6,958,371 shares in issue. The market capitalisation of Hepion Pharmaceuticals is US$4.96 million. Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.10.

HEPA 最新ニュース

その他のニュース

Form 8-K - Current report
Edgar (US Regulatory)
2025年3月21日
HEPA (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
2025年3月20日
HEPA (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
2025年3月11日
HEPA (0.00%)

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Edgar (US Regulatory)
2025年1月13日
HEPA (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
2024年12月11日
HEPA (0.00%)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.0328-4.397961920090.74580.890.5538102950.79053146CS
40.563375.3333333330.150.950.0203259382770.08106238CS
120.25756.35964912280.4560.950.0203214602410.14823027CS
260.0538.03030303030.660.950.020396210510.14956917CS
52-1.567-68.72807017542.282.89990.020348014180.15793379CS
156-24.087-97.12524.826.60.020317516551.38568086CS
260-32.687-97.865269461133.4123.60.0203181097719.17433598CS

HEPA - Frequently Asked Questions (FAQ)

What is the current Hepion Pharmaceuticals share price?
The current share price of Hepion Pharmaceuticals is US$ 0.713
How many Hepion Pharmaceuticals shares are in issue?
Hepion Pharmaceuticals has 6,958,371 shares in issue
What is the market cap of Hepion Pharmaceuticals?
The market capitalisation of Hepion Pharmaceuticals is USD 4.96M
What is the 1 year trading range for Hepion Pharmaceuticals share price?
Hepion Pharmaceuticals has traded in the range of US$ 0.0203 to US$ 2.8999 during the past year
What is the PE ratio of Hepion Pharmaceuticals?
The price to earnings ratio of Hepion Pharmaceuticals is -0.1
What is the reporting currency for Hepion Pharmaceuticals?
Hepion Pharmaceuticals reports financial results in USD
What is the latest annual profit for Hepion Pharmaceuticals?
The latest annual profit of Hepion Pharmaceuticals is USD -48.93M
What is the registered address of Hepion Pharmaceuticals?
The registered address for Hepion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Hepion Pharmaceuticals website address?
The website address for Hepion Pharmaceuticals is www.hepion.com
Which industry sector does Hepion Pharmaceuticals operate in?
Hepion Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 77.53
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.05
(0.00%)
0
AACGATA Creativity Global
US$ 1.01
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.04
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 77.53
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.05
(0.00%)
0
AACGATA Creativity Global
US$ 1.01
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.04
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 77.53
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.05
(0.00%)
0
AACGATA Creativity Global
US$ 1.01
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.04
(0.00%)
0

HEPA Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
HEPA
Hepion Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す